You just read:

Jazz Pharmaceuticals And Gentium S.p.A. Announce Agreement For Jazz Pharmaceuticals To Acquire Gentium For $57.00 Per Share

News provided by

Jazz Pharmaceuticals plc

Dec 19, 2013, 04:43 ET